Transjugular intrahepatic portosystemic shunts (TIPS) for the prevention of variceal re-bleeding – A two decades experience
Open Access
- 9 January 2018
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 13 (1) , e0189414
Abstract
Transjugular intrahepatic portosystemic shunts (TIPS) are used in patients with cirrhosis for the prevention of variceal rebleeding. We retrospectively evaluated re-bleeding rate, patency, mortality, and transplant-free survival (TFS) in cirrhotic patients receiving TIPS implantation for variceal bleeding between 1994–2014. 286 patients received TIPS (n = 119 bare metal stents, n = 167 polytetrafluorethylene (PTFE)-covered stents) for prevention of variceal re-bleeding. Mean age was 55.1 years, median MELD was 11.8, and the main etiology of cirrhosis was alcoholic liver disease (70%). Median follow-up was 821 days. 67 patients (23%) experienced at least one re-bleeding event. Patients with PTFE-TIPS were at significantly lower risk for variceal re-bleeding than patients with bare metal stents (14% vs. 37%, OR:0.259; p<0.001) and had less need for stent revision (21% vs. 37%; p = 0.024). Patients with PTFE stent grafts showed lower mortality than patients with bare stents after 1 year (19% vs. 31%, p = 0.020) and 2 years (29% vs. 40%; p = 0.041) after TIPS implantation. Occurrence of hepatic encephalopathy after TIPS was similar between groups (20% vs. 24%, p = 0.449). PTFE-TIPS were more effective at preventing variceal re-bleeding than bare metal stents due to better patency. Since this tended to translate in improved survival, only covered stents should be implemented for bleeding prophylaxis when TIPS is indicated.Keywords
This publication has 39 references indexed in Scilit:
- Comparison study of Doppler ultrasound surveillance of expanded polytetrafluoroethylene‐covered stent versus bare stent in transjugular intrahepatic portosystemic shuntJournal of Clinical Ultrasound, 2010
- Recombinant factor VIIa for variceal bleeding in patients with advanced cirrhosis: A randomized, controlled trialHepatology, 2008
- Hepatic encephalopathy after transjugular intrahepatic portosystemic shunt insertion: a decade of experienceQJM: An International Journal of Medicine, 2008
- Evolving Consensus in Portal Hypertension Report of the Baveno IV Consensus Workshop on methodology of diagnosis and therapy in portal hypertensionJournal of Hepatology, 2005
- The role of transjugular intrahepatic portosystemic shunt in the management of portal hypertension†Hepatology, 2005
- Survival in patients undergoing transjugular intrahepatic portosystemic shunt: ePTFE-covered stentgrafts versus bare stentsHepatology, 2003
- Survival in Patients Undergoing Transjugular Intrahepatic Portosystemic Shunt: Eptfe–Covered Stentgrafts Versus Bare StentsHepatology, 2003
- A Proportional Hazards Model for the Subdistribution of a Competing RiskJournal of the American Statistical Association, 1999
- Transjugular intrahepatic portosystemic shunt stenosis and revision: early and midterm results.American Journal of Roentgenology, 1994
- A Class of $K$-Sample Tests for Comparing the Cumulative Incidence of a Competing RiskThe Annals of Statistics, 1988